← Back to headlines
ZyVersa Therapeutics Reports GAAP EPS of -$4.18
ZyVersa Therapeutics has reported a GAAP Earnings Per Share (EPS) of -$4.18.
31 Mar, 21:48 — 31 Mar, 21:48
Sources
Showing 1 of 1 sources
ZyVersa Therapeutics has reported a GAAP Earnings Per Share (EPS) of -$4.18.
